0001725160-22-000005.txt : 20220105
0001725160-22-000005.hdr.sgml : 20220105
20220105174928
ACCESSION NUMBER: 0001725160-22-000005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220103
FILED AS OF DATE: 20220105
DATE AS OF CHANGE: 20220105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blackwell Kimberly
CENTRAL INDEX KEY: 0001816465
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39263
FILM NUMBER: 22512649
MAIL ADDRESS:
STREET 1: C/O ZENTALIS PHARMACEUTICALS, LLC
STREET 2: 530 SEVENTH AVENUE, SUITE 2201
CITY: NEW YORK
STATE: NY
ZIP: 10018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zentalis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001725160
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 530 SEVENTH AVENUE, SUITE 2201
CITY: NEW YORK
STATE: NY
ZIP: 10018
BUSINESS PHONE: (212) 433-3791
MAIL ADDRESS:
STREET 1: 530 SEVENTH AVENUE, SUITE 2201
CITY: NEW YORK
STATE: NY
ZIP: 10018
FORMER COMPANY:
FORMER CONFORMED NAME: Zentalis Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20200107
FORMER COMPANY:
FORMER CONFORMED NAME: Zeno Pharma, LLC
DATE OF NAME CHANGE: 20171212
4
1
wf-form4_164142295564507.xml
FORM 4
X0306
4
2022-01-03
0
0001725160
Zentalis Pharmaceuticals, Inc.
ZNTL
0001816465
Blackwell Kimberly
C/O ZENTALIS PHARMACEUTICALS, INC.
1359 BROADWAY, SUITE 1710
NEW YORK
NY
10018
1
0
0
0
Common Stock
2022-01-03
4
M
0
1000
47.80
A
6000
D
Common Stock
2022-01-03
4
S
0
1000
83.74
D
5000
D
Stock Option (Right to Buy)
47.8
2022-01-03
4
M
0
1000
0
D
2030-06-30
Common Stock
1000.0
38000
D
The stock option exercise and sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2021.
The options vest and become exercisable in substantially equal monthly installments over the 36 months following the date of grant on July 1, 2020.
By: /s/ Melissa B. Epperly, Attorney-in-Fact for Kimberly Blackwell
2022-01-05